R for Research Scientists

Published on : Published by : BioBuzz Media

‘R’ is a popular statistics software program used widely in various research fields. Team taught by active researchers, this two day lecture and hands-on computer based laboratory workshop is designed [….]

Gene Editing with CRISPR

Published on : Published by : BioBuzz Media

This rigorous three day program is ideal for basic research and translational biology scientists who are looking for a balanced theoretical vs. hands-on introduction to CRISPR toolkit. Directed by Dr. [….]

Flow Cytometry: Principles, Methods and Applications

Published on : Published by : BioBuzz Media

This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. Developed and taught by active researchers, this workshop will focus on [….]

Take Control of Your Life Sciences Career: Get Skilled-up for the Biopharma Jobs of the Future Now

Published on : Published by : Steven Surdez

The life sciences industry is evolving rapidly into a world where lab experimentation will meet artificial intelligence, automation will merge with human ingenuity and hard-won wisdom, and the power of viral vectors, stem cells, nanotechnology, and gene editing tools will revolutionize health care as we know it.

Rockville’s Emmes Acquires UK-Based Orphan Reach

Published on : Published by : BioBuzz Media

ROCKVILLE, Md., May 12, 2021 /PRNewswire/ — Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, today announced that it has acquired Orphan Reach, a CRO specialized in clinical research related to rare diseases. Financial terms of the transaction were not disclosed.

Why Philadelphia is Poised to Become a Top Cell and Gene Therapy Cluster

The Discovery Labs King of Prussia PA
Published on : Published by : Alex Keown

The Discovery Labs’ 2.4 million square foot site in King of Prussia, PA provides all the necessary ingredients to accelerate speed to market for cell and gene therapy innovators. The Center for Breakthrough Medicines is a cell and gene therapy contract development and manufacturing organization (CDMO) for plasmid DNA, viral vectors, and cellular therapy products and is located on-site.

5 Questions with John Newby, CEO, Virginia Bio

Published on : Published by : Andy Eckert

John Newby is the CEO at Virginia Bio, the statewide non-profit trade association for the life science industry. Approximately 300 companies spanning biopharmaceuticals, medical devices, med tech, diagnostics, digital health, bioinformatics, agriculture, and industrial bio and related fields are based in Virginia, mainly clustered around research universities and medical institutions. Virginia Bio is the sole state affiliate and works closely with key national industry organizations BIO, AdvaMed, MDMA, PhRMA and We Work for Health.

Annual BioHealth Capital Region Forum Showcases Robust Growth Across 4th Largest Biopharma Cluster

Published on : Published by : Alex Keown

The Sixth Annual BioHealth Capital Region Forum brought together industry leaders from across the region who discussed the accomplishments and strengths of the region as its member companies continue to innovate new therapies and medicines in one of the strongest bio-hub regions in the United States.